Flow Sciences Taps Board Member Michael Gesser as New CFO

Flow Sciences, which provides advanced containment solutions for pharmaceutical and laboratory environments, is naming Michael Gesser Chief Financial Officer (CFO).

Gesser has been a member of Flow Sciences’ Board of Directors since 2021. He will continue as such while CFO, adding finance, accounting, tax, treasury, financial planning and analysis, and investor relations responsibilities.

How Flow Sciences Will Deploy New CFO

Working with Flow Sciences’ executive team, Gesser will now oversee financial strategy, capital structure management, budgeting, forecasting, and compliance. He will also support ongoing growth initiatives, building on award-winning company innovations such as the Vented Balance Safety Enclosure.

“Michael’s appointment as CFO is a natural evolution of his already-significant contributions,” said Flow Sciences CEO Jonathan Mann.

Mann praised Gesser’s “deep financial expertise,” “experience navigating both public and private company environments,” and “long-standing familiarity with our business.”

“I have had a front-row seat to Flow Sciences’ evolution,” Gesser said. He cited “the strength of its technology, the quality of its team, and the depth of its customer relationships.”

Gesser’s Impact Prior to CFO Appointment

Flow Sciences is headquartered in North Carolina. While on its board, Gesser has had a role in the company’s expansion into the state’s Research Triangle Park section. That office opened in 2025 and boasts a state-of-the-art product showroom, training facilities, and consultative design center.

Additionally, this is not Gesser’s first appointment as a CFO. He has previously served in that role for Acorda Therapeutics, Osmotica Pharmaceutical, Tergus Pharma, BioMedomics, and SunTech Medical.

He now takes the financial reins as Flow Sciences seeks to expand its containment solutions portfolio

“There is a tremendous opportunity ahead of us, and I look forward to helping the company capitalize,” Gesser said.